Mode
Text Size
Log in / Sign up
N/A N=99 Randomized Double-blind Other

Ketamine/Placebo Family History Positive Study

Alcoholism

Enrolled (actual)
99
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcome: Primary: Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation — 0.63; 0.96; 0.71; 1.25 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Ketamine and Placebo (Drug)
Age
Adult · 21+ yrs
Sex
All
Sponsor
Yale University
Primary completion
Jun 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation
7.46; 9.99; 1.07; 0.92
PRIMARY
Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation
7.46; 9.99; 1.07; 0.92
PRIMARY
Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation
7.46; 9.99; 1.07; 0.92
PRIMARY
Biphasic Alcohol Effects Scale (BAES) - Subscale Sedation
7.46; 9.99; 1.07; 0.92
PRIMARY
Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation
3.81; 3.02; 1.61; 2.12
PRIMARY
Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation
3.81; 3.02; 1.61; 2.12
PRIMARY
Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation
3.81; 3.02; 1.61; 2.12
PRIMARY
Biphasic Alcohol Effects Scale (BAES) - Subscale Stimulation
3.81; 3.02; 1.61; 2.12

Summary

The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.

Eligibility Criteria

Inclusion Criteria

  • Male and female between the ages of 21 and 30 years
  • Medically and neurologically healthy on the basis of history, physical examination, EKG, screening laboratories, absence of current and/or past substance abuse

For Family History Positive (FHP) Subjects: Biological father and another first or second-degree biological relative with history of alcoholism

Exclusion Criteria

  • Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) psychiatric and substance abuse diagnosis by history on psychiatric evaluation that includes a structured diagnostic interview (The Semi-Structured Assessment for the Genetics of alcoholism: SSAGA) and the Wisconsin Scales of Psychosis Proneness
  • History of counseling or psychotherapy; except family therapy centered around another family member
  • Extended unwillingness to remain alcohol-free for three days prior to testing and for the duration of the testing period
  • For women: positive pregnancy test at screening or intention to engage in unprotected sex during the study
  • Alcohol naïve
  • Previous bad experience with ketamine
  • Adoptee and no contact with family members

For Family History Negative (FHN) Subjects: NO family history of alcoholism in any first or second-degree relatives (subjects must reliably report on three first-degree relatives)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00588952). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search